En Bloc Pancreaticoduodenectomy and Right Colectomy in the Treatment of Locally Advanced Colon Cancer

医学 胰十二指肠切除术 结直肠癌 结肠切除术 外科 胰瘘 普通外科 癌症 胰腺 内科学 切除术
作者
Ji Zhang,Jiahua Leng,Hong-Gang Qian,Hui Qiu,Jianhui Wu,Bo-nan Liu,Chengpeng Li,Chunyi Hao
出处
期刊:Diseases of The Colon & Rectum [Lippincott Williams & Wilkins]
卷期号:56 (7): 874-880 被引量:35
标识
DOI:10.1097/dcr.0b013e3182941704
摘要

BACKGROUD: Carcinoma of the right colon invading the pancreas or duodenum is rare. Evidence of the indication, operative morbidity, and survival of en bloc pancreaticoduodenectomy and right colectomy for right colon cancer invading adjacent organs is limited. OBJECTIVE: The goal of this study was to investigate the feasibility, safety, indication, and long-term results of en bloc pancreaticoduodenectomy and right colectomy in the treatment of locally advanced right-sided colon cancer. DESIGN: This was a retrospective analysis of all inpatients undergoing en bloc pancreaticoduodenectomy and right colectomy. Detailed data of these patients were assessed by a thorough review of medical charts. SETTINGS: The study was conducted using a hospital database. PATIENTS: Fourteen patients who underwent en bloc pancreaticoduodenectomy and right colectomy from January 1989 through December 2011 were included in the study. MAIN OUTCOME MEASURES: In-hospital complications, mortality, and survival were the primary outcomes measured. RESULTS: Major postoperative complications included delayed gastric empting (n = 7), class B pancreatic fistula (n = 3), and bile leakage (n = 1). Postoperative death occurred in 2 patients. The median hospital stay was 22.5 days (range, 17.0–57.0 days). Inflammatory adhesion was confirmed by pathologic examination in only 1 patient. Eight patients (57%) did not have lymph node metastasis. The median follow-up time was 21 months (range, 4–276 months). Ten patients were alive at the time of their last scheduled follow-up. The overall survival rates were 72% at 1 year and 60% at 2 years. No patient was lost to follow-up. Three patients developed tumor recurrence. The outcomes are no worse than those of the stage-matched patients without adjacent organ involvement and are much better than those of the stage-matched patients who underwent bypass surgery and chemotherapy. LIMITATIONS: The number of patients in current studies is limited. CONCLUSIONS: En bloc pancreaticoduodenectomy and right colectomy can be performed safely with an acceptable morbidity and mortality rate in selected patients with locally advanced right-side colon cancer. The long-term results are promising.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Mocca完成签到,获得积分10
刚刚
刘壮完成签到,获得积分10
刚刚
1秒前
Mr完成签到,获得积分20
1秒前
猫毛发布了新的文献求助10
1秒前
繁荣的行天完成签到,获得积分10
1秒前
wei完成签到,获得积分10
1秒前
1秒前
2秒前
3秒前
奋斗土豆发布了新的文献求助10
3秒前
4秒前
5秒前
在水一方应助漫漫采纳,获得10
5秒前
徐醉蝶完成签到,获得积分10
5秒前
6秒前
6秒前
YKT发布了新的文献求助30
7秒前
袋袋完成签到,获得积分10
8秒前
猫毛完成签到,获得积分10
8秒前
kumi发布了新的文献求助10
9秒前
流放的小胡完成签到,获得积分10
9秒前
真实的芯发布了新的文献求助10
10秒前
lucky37应助药多多采纳,获得10
10秒前
10秒前
11秒前
元气马发布了新的文献求助10
11秒前
光明磊落完成签到,获得积分10
11秒前
你嵙这个期刊没买应助anis采纳,获得50
11秒前
Emma发布了新的文献求助10
11秒前
caopeili完成签到 ,获得积分10
11秒前
谢大喵完成签到,获得积分10
12秒前
ZZZ发布了新的文献求助10
12秒前
领导范儿应助无心的寻芹采纳,获得10
13秒前
感动冬灵完成签到 ,获得积分10
13秒前
侏罗纪世界完成签到,获得积分10
14秒前
14秒前
14秒前
刁山山发布了新的文献求助10
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 2500
Atlas of Aligner Treatment and Planning A Case-Based Approach 1000
Rocket Propulsion Elements, 10th Edition 800
悉尼大学博士学位论文,题目:Modelling and testing of one-sided stitched laminated composites. 作者:Kristopher P. Plain 700
Soil mites of the family Rhagidiidae (Actinedida: Eupodoidea). Morphology, Systematics, Ecology 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7442769
求助须知:如何正确求助?哪些是违规求助? 9043931
关于积分的说明 19278092
捐赠科研通 7067697
什么是DOI,文献DOI怎么找? 3238504
关于科研通互助平台的介绍 2402093
邀请新用户注册赠送积分活动 2222553